Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China

Схожие документы

• Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
  по: Chathika K. Weerasuriya, и др.
  Опубликовано: (2022-03-01)
• Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis
  по: Chathika Krishan Weerasuriya, и др.
  Опубликовано: (2021-03-01)
• Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India
  по: Rebecca C. Harris, и др.
  Опубликовано: (2022-02-01)
• Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis.
  по: Chaelin Kim, и др.
  Опубликовано: (2025-01-01)
• Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.
  по: Naomi M Fuller, и др.
  Опубликовано: (2024-04-01)